AVTR as reported
Avantor, Inc. reported $6.55B of revenue over the trailing twelve months, −2.0% on the year before. 11 reported series are charted on this page, each one as filed.
$6.55B
Revenue, trailing twelve months · to Q1 2026 · −2.0% against the twelve months before
- Net Income
- −$551M
Net Income · −177% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $439M
Free Cash Flow · −34% year on year · trailing twelve months to Q1 2026
- Op Margin
- −4.6%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $6.55B | −2.0% | Q1 2026 |
| Net Income | −$551M | −177% | Q1 2026 |
| EPS | −$0.81 | −178% | Q1 2026 |
| Gross Margin | 32% | n/a | Q1 2026 |
| Op Margin | −4.6% | n/a | Q1 2026 |
| Net Margin | −8.5% | n/a | Q1 2026 |
| ROE | −2.5% | n/a | Q1 2026 |
| ROA | −1.1% | n/a | Q1 2026 |
| ROIC | 1.4% | n/a | Q1 2026 |
| Free Cash Flow | $439M | −34% | Q1 2026 |
| P/E | 26.7 | n/a | Q2 2025 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Avantor, Inc. (AVTR) - Revenue & ProfitRevenue & ProfitAvantor, Inc. (AVTR)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Instruments & Supplies
Ranks #22 of 27 by Smart Score